Literature DB >> 28261972

Balanced covariates with response adaptive randomization.

Benjamin R Saville1,2, Scott M Berry1,3.   

Abstract

Response adaptive randomization (RAR) methods for clinical trials are susceptible to imbalance in the distribution of influential covariates across treatment arms. This can make the interpretation of trial results difficult, because observed differences between treatment groups may be a function of the covariates and not necessarily because of the treatments themselves. We propose a method for balancing the distribution of covariate strata across treatment arms within RAR. The method uses odds ratios to modify global RAR probabilities to obtain stratum-specific modified RAR probabilities. We provide illustrative examples and a simple simulation study to demonstrate the effectiveness of the strategy for maintaining covariate balance. The proposed method is straightforward to implement and applicable to any type of RAR method or outcome.
Copyright © 2017 John Wiley & Sons, Ltd.

Keywords:  Bayesian RAR, clinical trial, covariate balance, imbalance, response adaptive randomization, stratification

Mesh:

Year:  2017        PMID: 28261972     DOI: 10.1002/pst.1803

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  3 in total

1.  A learning health system approach to the COVID-19 pandemic: System-wide changes in clinical practice and 30-day mortality among hospitalized patients.

Authors:  Erin K McCreary; Kevin E Kip; J Ryan Bariola; Mark Schmidhofer; Tami Minnier; Katelyn Mayak; Debbie Albin; Jessica Daley; Kelsey Linstrum; Erik Hernandez; Rachel Sackrowitz; Kailey Hughes; Christopher Horvat; Graham M Snyder; Bryan J McVerry; Donald M Yealy; David T Huang; Derek C Angus; Oscar C Marroquin
Journal:  Learn Health Syst       Date:  2022-01-27

2.  Statistical advances in clinical trials and clinical research.

Authors:  Guogen Shan; Sarah Banks; Justin B Miller; Aaron Ritter; Charles Bernick; Joseph Lombardo; Jeffrey L Cummings
Journal:  Alzheimers Dement (N Y)       Date:  2018-06-14

3.  Implementation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 (REMAP-COVID) trial in a US health system-lessons learned and recommendations.

Authors: 
Journal:  Trials       Date:  2021-01-28       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.